News | December 19, 2025
ystral expands in India with new Bangalore facility, boosting team & local production
The expansion includes a larger technical and service team and increased local procurement
The expansion includes a larger technical and service team and increased local procurement
The state-of-the-art facility is a 350-bedded, multi-specialty tertiary care hospital
The drug is currently being evaluated in two fully recruited global Phase 3 studies for progressive and tophaceous gout, with results expected in 2026.
The inspection concluded with one minor observation in Form 483
The new centre brings advanced corneal procedures pioneered in India
The cobas Mass Spec solution Ionify reagent portfolio now covers therapeutic drug monitoring for immunosuppressants and antibiotics
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
Dr Reddy’s will pay Immutep US$ 20 million upfront and could deliver as much as US$ 349.5 million in regulatory and commercial milestones
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Subscribe To Our Newsletter & Stay Updated
